Clinical Trials Browser

Phase 3 × fluzoparib × Gastrointestinal × Clear all

NCT04300114 2024-03-28

A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

Phase 3 Terminated

Gastrointestinal

Pancreatic Neoplasms